Literature DB >> 21767791

[The "outcome benchmarking in rheumatologic acute care" project of the Association of Rheumatologic Acute Care Clinics (VRA e.V.) in Germany].

Norbert Roeder1, Heinz-Jürgen Lakomek.   

Abstract

By initiating and taking part in the pilot project obra (outcome benchmarking in rheumatologic acute care), which was supported by the German Ministry of Health, the rheumatologic hospitals committed themselves to the continuous improvement of quality through a collective benchmarking and learning process. In addition to verifiable and concrete improvements in quality, the major achievements of the obra pilot project include a cultural change in the participating hospitals as well as the continuation of outcome benchmarking and its expansion to an increasing number of hospitals.
Copyright © 2011. Published by Elsevier GmbH.

Mesh:

Year:  2011        PMID: 21767791     DOI: 10.1016/j.zefq.2011.05.013

Source DB:  PubMed          Journal:  Z Evid Fortbild Qual Gesundhwes        ISSN: 1865-9217


  9 in total

1.  [Hospital financing in 2015. Relevant changes for rheumatology].

Authors:  W Fiori; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2015-06       Impact factor: 1.372

2.  [Hospital financing in 2013: relevant changes for rheumatology].

Authors:  W Fiori; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2013-04       Impact factor: 1.372

3.  [Hospital financing in 2014. Relevant changes for rheumatology].

Authors:  W Fiori; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2014-03       Impact factor: 1.372

Review 4.  [Hospital financing in 2016. Relevant changes for rheumatology].

Authors:  W Fiori; H Bunzemeier; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372

Review 5.  [Rheumatological care in the Rheumazentrum Ruhrgebiet Rheumatism Center-a model for conurbations].

Authors:  J Braun; U Kiltz; I Andreica; B Buehring; B Guminski; U Häusler; H Kavruk; D Kiefer; R Lochowski; B Mintrop; X Baraliakos
Journal:  Z Rheumatol       Date:  2019-10       Impact factor: 1.372

Review 6.  [Treat-to-target (T2T) from the perspective of inpatient rheumatology].

Authors:  H-J Lakomek; A Krause
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

7.  [How to finance and increase the appeal of rheumatology training : view of the Association of Rheumatology Clinics in Germany (VRA) on challenges and successful strategies].

Authors:  H-J Lakomek; J Robbers; R Koshedub; A Krause; J Braun
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

8.  [Cornerstones of quality assurance in medicine in Germany. Important impulse for the situation in treatment of rheumatism].

Authors:  J Braun; M Schneider; H-J Lakomek
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372

9.  [Quality in acute inpatient rheumatology 2021 : Current aspects of the KOBRA quality label of the Association of Rheumatological Acute Care Clinics].

Authors:  H-J Lakomek; M Rudwaleit; A Hentschel; B Broge; J Abrolat; F Bessler; B Hellmich; A Klemann; A Krause; M Klass; J Strunk; W Fiori; N Roeder; J Braun
Journal:  Z Rheumatol       Date:  2021-05-17       Impact factor: 1.372

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.